Skip to main content
Erschienen in: Der Nervenarzt 4/2017

07.02.2017 | Zecken | CME

Neuroborreliose – Diagnostik, Therapie und Verlauf

verfasst von: Dr. R. Dersch, S. Rauer

Erschienen in: Der Nervenarzt | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die Neuroborreliose ist eine durch Zecken übertragene Infektionskrankheit, ausgelöst durch das Spirochätenbakterium Borrelia burgdorferi sensu lato. Die klinische Symptomatik wird in Früh- und Spätmanifestationen eingeteilt. Frühmanifestationen sind deutlich häufiger als Spätmanifestationen. Eine serologische Diagnostik sollte nur bei konkretem klinischem Verdacht erfolgen, da falsch-positive Befunde aufgrund der hohen Seroprävalenz häufig sind. Zur Abklärung einer Neuroborreliose gehört eine Liquoruntersuchung. Bei der Therapie sind Betalaktamantibiotika und Doxycyclin nach einer systematischen Übersichtsarbeit gleichwertig hinsichtlich neurologischer Symptome und Nebenwirkungen. Die Prognose nach antibiotischer Behandlung ist in der Regel gut. Defektheilungen sind möglich, aber selten. Einschränkungen der Lebensqualität, Fatigue, Depression und kognitive Einschränkungen treten bei Patienten nach einer behandelten Neuroborreliose nicht häufiger auf als in der gesunden Normalbevölkerung.
Literatur
1.
Zurück zum Zitat Halperin JJ (2012) Lyme disease: a multisystem infection that affects the nervous system. Contin Minneap Minn 18(6 Infectious Disease):1338–1350 Halperin JJ (2012) Lyme disease: a multisystem infection that affects the nervous system. Contin Minneap Minn 18(6 Infectious Disease):1338–1350
2.
Zurück zum Zitat Huppertz HI, Böhme M, Standaert SM, Karch H, Plotkin SA (1999) Incidence of Lyme borreliosis in the Würzburg region of Germany. Eur J Clin Microbiol Infect Dis 18(10):697–703CrossRefPubMed Huppertz HI, Böhme M, Standaert SM, Karch H, Plotkin SA (1999) Incidence of Lyme borreliosis in the Würzburg region of Germany. Eur J Clin Microbiol Infect Dis 18(10):697–703CrossRefPubMed
3.
4.
Zurück zum Zitat von Wissmann B, Hautmann W, Sing A, Hizo-Teufel C, Fingerle V (2015) Assessing the risk of human granulocytic anaplasmosis and lyme borreliosis after a tick bite in Bavaria, Germany. Int J Med Microbiol 305(7):736–741CrossRef von Wissmann B, Hautmann W, Sing A, Hizo-Teufel C, Fingerle V (2015) Assessing the risk of human granulocytic anaplasmosis and lyme borreliosis after a tick bite in Bavaria, Germany. Int J Med Microbiol 305(7):736–741CrossRef
6.
Zurück zum Zitat Robert Koch Institut (2015) Meldepflicht für Lyme-Borreliose in Bayern – eine erste Bilanz. Epidemiol Bull 8/2015:1–8 Robert Koch Institut (2015) Meldepflicht für Lyme-Borreliose in Bayern – eine erste Bilanz. Epidemiol Bull 8/2015:1–8
7.
Zurück zum Zitat Nahimana I, Gern L, Blanc DS, Praz G, Francioli P, Péter O (2004) Risk of Borrelia burgdorferi infection in western Switzerland following a tick bite. Eur J Clin Microbiol Infect Dis 23(8):603–608CrossRefPubMed Nahimana I, Gern L, Blanc DS, Praz G, Francioli P, Péter O (2004) Risk of Borrelia burgdorferi infection in western Switzerland following a tick bite. Eur J Clin Microbiol Infect Dis 23(8):603–608CrossRefPubMed
8.
Zurück zum Zitat Rauer S (2012) S1 Leitlinie Neuroborreliose. Leitlinien für Diagnostik und Therapie in der Neurologie. Thieme, Stuttgart Rauer S (2012) S1 Leitlinie Neuroborreliose. Leitlinien für Diagnostik und Therapie in der Neurologie. Thieme, Stuttgart
9.
Zurück zum Zitat Boulanger N (2007) What primary prevention should be used to prevent Lyme disease? Méd Mal Infect 37(7–8):456–462CrossRefPubMed Boulanger N (2007) What primary prevention should be used to prevent Lyme disease? Méd Mal Infect 37(7–8):456–462CrossRefPubMed
10.
Zurück zum Zitat Faulde MK, Rutenfranz M, Keth A, Hepke J, Rogge M, Görner A (2015) Pilot study assessing the effectiveness of factory-treated, long-lasting permethrin-impregnated clothing for the prevention of tick bites during occupational tick exposure in highly infested military training areas, Germany. Parasitol Res 114(2):671–678CrossRefPubMed Faulde MK, Rutenfranz M, Keth A, Hepke J, Rogge M, Görner A (2015) Pilot study assessing the effectiveness of factory-treated, long-lasting permethrin-impregnated clothing for the prevention of tick bites during occupational tick exposure in highly infested military training areas, Germany. Parasitol Res 114(2):671–678CrossRefPubMed
11.
Zurück zum Zitat Pfister HW, Einhäupl KM, Wilske B, Preac-Mursic V (1987) Bannwarth’s syndrome and the enlarged neurological spectrum of arthropod-borne borreliosis. Zentralbl Bakteriol Mikrobiol Hyg A Med Microbiol Infect Dis Virol Parasitol 263(3):343–347 Pfister HW, Einhäupl KM, Wilske B, Preac-Mursic V (1987) Bannwarth’s syndrome and the enlarged neurological spectrum of arthropod-borne borreliosis. Zentralbl Bakteriol Mikrobiol Hyg A Med Microbiol Infect Dis Virol Parasitol 263(3):343–347
12.
Zurück zum Zitat Back T, Grünig S, Winter Y, Bodechtel U, Guthke K, Khati D et al (2013) Neuroborreliosis-associated cerebral vasculitis: long-term outcome and health-related quality of life. J Neurol 260(6):1569–1575CrossRefPubMed Back T, Grünig S, Winter Y, Bodechtel U, Guthke K, Khati D et al (2013) Neuroborreliosis-associated cerebral vasculitis: long-term outcome and health-related quality of life. J Neurol 260(6):1569–1575CrossRefPubMed
13.
Zurück zum Zitat Mygland A, Skarpaas T, Ljøstad U (2006) Chronic polyneuropathy and lyme disease. Eur J Neurol 13(11):1213–1215CrossRefPubMed Mygland A, Skarpaas T, Ljøstad U (2006) Chronic polyneuropathy and lyme disease. Eur J Neurol 13(11):1213–1215CrossRefPubMed
14.
Zurück zum Zitat Mygland A, Ljøstad U, Fingerle V, Rupprecht T, Schmutzhard E, Steiner I et al (2010) EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol Januar 17(1):8–16 (e1–4)CrossRef Mygland A, Ljøstad U, Fingerle V, Rupprecht T, Schmutzhard E, Steiner I et al (2010) EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol Januar 17(1):8–16 (e1–4)CrossRef
15.
Zurück zum Zitat Wilske B, Fingerle V, Schulte-Spechtel U (2007) Microbiological and serological diagnosis of Lyme borreliosis. FEMS Immunol Med Microbiol 49(1):13–21CrossRefPubMed Wilske B, Fingerle V, Schulte-Spechtel U (2007) Microbiological and serological diagnosis of Lyme borreliosis. FEMS Immunol Med Microbiol 49(1):13–21CrossRefPubMed
16.
Zurück zum Zitat Wilking H, Fingerle V, Klier C, Thamm M, Stark K (2015) Antibodies against Borrelia burgdorferi sensu lato among Adults, Germany, 2008–2011. Emerg Infect Dis 21(1):107–110CrossRefPubMedPubMedCentral Wilking H, Fingerle V, Klier C, Thamm M, Stark K (2015) Antibodies against Borrelia burgdorferi sensu lato among Adults, Germany, 2008–2011. Emerg Infect Dis 21(1):107–110CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Oehme R, Hartelt K, Backe H, Brockmann S, Kimmig P (2002) Foci of tick-borne diseases in southwest Germany. Int J Med Microbiol 291(Suppl 33):22–29CrossRefPubMed Oehme R, Hartelt K, Backe H, Brockmann S, Kimmig P (2002) Foci of tick-borne diseases in southwest Germany. Int J Med Microbiol 291(Suppl 33):22–29CrossRefPubMed
18.
Zurück zum Zitat Hammers-Berggren S, Hansen K, Lebech AM, Karlsson M (1993) Borrelia burgdorferi-specific intrathecal antibody production in neuroborreliosis: a follow-up study. Neurology 43(1):169–175CrossRefPubMed Hammers-Berggren S, Hansen K, Lebech AM, Karlsson M (1993) Borrelia burgdorferi-specific intrathecal antibody production in neuroborreliosis: a follow-up study. Neurology 43(1):169–175CrossRefPubMed
19.
Zurück zum Zitat Hilton E, Tramontano A, DeVoti J, Sood SK (1997) Temporal study of immunoglobin M seroreactivity to Borrelia burgdorferi in patients treated for Lyme borreliosis. J Clin Microbiol 35(3):774–776PubMedPubMedCentral Hilton E, Tramontano A, DeVoti J, Sood SK (1997) Temporal study of immunoglobin M seroreactivity to Borrelia burgdorferi in patients treated for Lyme borreliosis. J Clin Microbiol 35(3):774–776PubMedPubMedCentral
20.
Zurück zum Zitat Hansen K, Lebech AM (1992) The clinical and epidemiological profile of Lyme neuroborreliosis in Denmark 1985–1990. A prospective study of 187 patients with Borrelia burgdorferi specific intrathecal antibody production. Brain J Neurol April 115(Pt 2):399–423CrossRef Hansen K, Lebech AM (1992) The clinical and epidemiological profile of Lyme neuroborreliosis in Denmark 1985–1990. A prospective study of 187 patients with Borrelia burgdorferi specific intrathecal antibody production. Brain J Neurol April 115(Pt 2):399–423CrossRef
21.
Zurück zum Zitat Nadelman RB, Hanincová K, Mukherjee P, Liveris D, Nowakowski J, McKenna D et al (2012) Differentiation of reinfection from relapse in recurrent Lyme disease. N Engl J Med 367(20):1883–1890CrossRefPubMedPubMedCentral Nadelman RB, Hanincová K, Mukherjee P, Liveris D, Nowakowski J, McKenna D et al (2012) Differentiation of reinfection from relapse in recurrent Lyme disease. N Engl J Med 367(20):1883–1890CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Kaiser R (1994) Variable CSF findings in early and late Lyme neuroborreliosis: a follow-up study in 47 patients. J Neurol 242(1):26–36CrossRefPubMed Kaiser R (1994) Variable CSF findings in early and late Lyme neuroborreliosis: a follow-up study in 47 patients. J Neurol 242(1):26–36CrossRefPubMed
23.
Zurück zum Zitat Djukic M, Schmidt-Samoa C, Lange P, Spreer A, Neubieser K, Eiffert H et al (2012) Cerebrospinal fluid findings in adults with acute Lyme neuroborreliosis. J Neurol 259(4):630–636CrossRefPubMed Djukic M, Schmidt-Samoa C, Lange P, Spreer A, Neubieser K, Eiffert H et al (2012) Cerebrospinal fluid findings in adults with acute Lyme neuroborreliosis. J Neurol 259(4):630–636CrossRefPubMed
24.
Zurück zum Zitat Kaiser R (2004) Clinical courses of acute and chronic neuroborreliosis following treatment with ceftriaxone. Nervenarzt 75(6):553–557CrossRefPubMed Kaiser R (2004) Clinical courses of acute and chronic neuroborreliosis following treatment with ceftriaxone. Nervenarzt 75(6):553–557CrossRefPubMed
25.
Zurück zum Zitat Tumani H, Nölker G, Reiber H (1995) Relevance of cerebrospinal fluid variables for early diagnosis of neuroborreliosis. Neurology 45(9):1663–1670CrossRefPubMed Tumani H, Nölker G, Reiber H (1995) Relevance of cerebrospinal fluid variables for early diagnosis of neuroborreliosis. Neurology 45(9):1663–1670CrossRefPubMed
26.
Zurück zum Zitat Kaiser R, Lücking CH (1993) Intrathecal synthesis of specific antibodies in neuroborreliosis. Comparison of different ELISA techniques and calculation methods. J Neurol Sci 118(1):64–72CrossRefPubMed Kaiser R, Lücking CH (1993) Intrathecal synthesis of specific antibodies in neuroborreliosis. Comparison of different ELISA techniques and calculation methods. J Neurol Sci 118(1):64–72CrossRefPubMed
27.
Zurück zum Zitat Kalish RA, McHugh G, Granquist J, Shea B, Ruthazer R, Steere AC (2001) Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10–20 years after active Lyme disease. Clin Infect Dis 33(6):780–785CrossRefPubMed Kalish RA, McHugh G, Granquist J, Shea B, Ruthazer R, Steere AC (2001) Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10–20 years after active Lyme disease. Clin Infect Dis 33(6):780–785CrossRefPubMed
28.
Zurück zum Zitat Leeflang MMG, Ang CW, Berkhout J, Bijlmer HA, Van Bortel W, Brandenburg AH, et al (2016) The diagnostic accuracy of serological tests for Lyme borreliosis in Europe: a systematic review and meta-analysis. BMC Infect Dis 16:140 Leeflang MMG, Ang CW, Berkhout J, Bijlmer HA, Van Bortel W, Brandenburg AH, et al (2016) The diagnostic accuracy of serological tests for Lyme borreliosis in Europe: a systematic review and meta-analysis. BMC Infect Dis 16:140
29.
Zurück zum Zitat Krumbholz M, Theil D, Cepok S, Hemmer B, Kivisäkk P, Ransohoff RM et al (2006) Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. Brain J Neurol 129(Pt 1):200–211 Krumbholz M, Theil D, Cepok S, Hemmer B, Kivisäkk P, Ransohoff RM et al (2006) Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. Brain J Neurol 129(Pt 1):200–211
30.
Zurück zum Zitat Rupprecht TA, Plate A, Adam M, Wick M, Kastenbauer S, Schmidt C et al (2009) The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis. J Neuroinflammation 6:42CrossRefPubMedPubMedCentral Rupprecht TA, Plate A, Adam M, Wick M, Kastenbauer S, Schmidt C et al (2009) The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis. J Neuroinflammation 6:42CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Senel M, Rupprecht TA, Tumani H, Pfister HW, Ludolph AC, Brettschneider J (2010) The chemokine CXCL13 in acute neuroborreliosis. J Neurol Neurosurg Psychiatry 81(8):929–933CrossRefPubMed Senel M, Rupprecht TA, Tumani H, Pfister HW, Ludolph AC, Brettschneider J (2010) The chemokine CXCL13 in acute neuroborreliosis. J Neurol Neurosurg Psychiatry 81(8):929–933CrossRefPubMed
32.
Zurück zum Zitat Rupprecht TA, Koedel U, Angele B, Fingerle V, Pfister H‑W (2006) Cytokine CXCL13 – a possible early CSF marker for neuroborreliosis. Nervenarzt 77(4):470–473CrossRefPubMed Rupprecht TA, Koedel U, Angele B, Fingerle V, Pfister H‑W (2006) Cytokine CXCL13 – a possible early CSF marker for neuroborreliosis. Nervenarzt 77(4):470–473CrossRefPubMed
33.
Zurück zum Zitat van Burgel ND, Bakels F, Kroes ACM, van Dam AP (2011) Discriminating Lyme neuroborreliosis from other neuroinflammatory diseases by levels of CXCL13 in cerebrospinal fluid. J Clin Microbiol 49(5):2027–2030CrossRefPubMedPubMedCentral van Burgel ND, Bakels F, Kroes ACM, van Dam AP (2011) Discriminating Lyme neuroborreliosis from other neuroinflammatory diseases by levels of CXCL13 in cerebrospinal fluid. J Clin Microbiol 49(5):2027–2030CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Dersch R, Hottenrott T, Senel M, Lehmensiek V, Tumani H, Rauer S et al (2015) The chemokine CXCL13 is elevated in the cerebrospinal fluid of patients with neurosyphilis. Fluids Barriers CNS 12:12CrossRefPubMedPubMedCentral Dersch R, Hottenrott T, Senel M, Lehmensiek V, Tumani H, Rauer S et al (2015) The chemokine CXCL13 is elevated in the cerebrospinal fluid of patients with neurosyphilis. Fluids Barriers CNS 12:12CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Dersch R, Freitag MH, Schmidt S, Sommer H, Rauer S, Meerpohl JJ (2015) Efficacy and safety of pharmacological treatments for acute Lyme neuroborreliosis – a systematic review. Eur J Neurol 22(9):1249–1259CrossRefPubMed Dersch R, Freitag MH, Schmidt S, Sommer H, Rauer S, Meerpohl JJ (2015) Efficacy and safety of pharmacological treatments for acute Lyme neuroborreliosis – a systematic review. Eur J Neurol 22(9):1249–1259CrossRefPubMed
36.
Zurück zum Zitat Bensch J, Olcén P, Hagberg L (1987) Destructive chronic borrelia meningoencephalitis in a child untreated for 15 years. Scand J Infect Dis 19(6):697–700CrossRefPubMed Bensch J, Olcén P, Hagberg L (1987) Destructive chronic borrelia meningoencephalitis in a child untreated for 15 years. Scand J Infect Dis 19(6):697–700CrossRefPubMed
37.
Zurück zum Zitat Karlsson M, Hammers-Berggren S, Lindquist L, Stiernstedt G, Svenungsson B (1994) Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis. Neurology 44(7):1203–1207CrossRefPubMed Karlsson M, Hammers-Berggren S, Lindquist L, Stiernstedt G, Svenungsson B (1994) Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis. Neurology 44(7):1203–1207CrossRefPubMed
38.
Zurück zum Zitat Ljøstad U, Skogvoll E, Eikeland R, Midgard R, Skarpaas T, Berg A et al (2008) Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial. Lancet Neurol 7(8):690–695CrossRefPubMed Ljøstad U, Skogvoll E, Eikeland R, Midgard R, Skarpaas T, Berg A et al (2008) Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial. Lancet Neurol 7(8):690–695CrossRefPubMed
39.
Zurück zum Zitat Kohlhepp W, Oschmann P, Mertens HG (1989) Treatment of Lyme borreliosis. Randomized comparison of doxycycline and penicillin G. J Neurol 236(8):464–469CrossRefPubMed Kohlhepp W, Oschmann P, Mertens HG (1989) Treatment of Lyme borreliosis. Randomized comparison of doxycycline and penicillin G. J Neurol 236(8):464–469CrossRefPubMed
40.
Zurück zum Zitat Halperin JJ, Shapiro ED, Logigian E, Belman AL, Dotevall L, Wormser GP et al (2007) Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the quality standards subcommittee of the American Academy of Neurology. Neurology 69(1):91–102CrossRefPubMed Halperin JJ, Shapiro ED, Logigian E, Belman AL, Dotevall L, Wormser GP et al (2007) Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the quality standards subcommittee of the American Academy of Neurology. Neurology 69(1):91–102CrossRefPubMed
41.
Zurück zum Zitat Viader F, Poncelet AM, Chapon F, Thenint JP, Dupuy B, Morin P et al (1989) Neurologic forms of Lyme disease. 12 cases. Rev Neurol 145(5):362–368PubMed Viader F, Poncelet AM, Chapon F, Thenint JP, Dupuy B, Morin P et al (1989) Neurologic forms of Lyme disease. 12 cases. Rev Neurol 145(5):362–368PubMed
42.
Zurück zum Zitat Bateman DE, Lawton NF, White JE, Greenwood RJ, Wright DJ (1988) The neurological complications of Borrelia burgdorferi in the new forest area of Hampshire. J Neurol Neurosurg Psychiatry 51(5):699–703CrossRefPubMedPubMedCentral Bateman DE, Lawton NF, White JE, Greenwood RJ, Wright DJ (1988) The neurological complications of Borrelia burgdorferi in the new forest area of Hampshire. J Neurol Neurosurg Psychiatry 51(5):699–703CrossRefPubMedPubMedCentral
43.
Zurück zum Zitat Oksi J, Nikoskelainen J, Hiekkanen H, Lauhio A, Peltomaa M, Pitkäranta A et al (2007) Duration of antibiotic treatment in disseminated Lyme borreliosis: a double-blind, randomized, placebo-controlled, multicenter clinical study. Eur J Clin Microbiol Infect Dis 26(8):571–581CrossRefPubMed Oksi J, Nikoskelainen J, Hiekkanen H, Lauhio A, Peltomaa M, Pitkäranta A et al (2007) Duration of antibiotic treatment in disseminated Lyme borreliosis: a double-blind, randomized, placebo-controlled, multicenter clinical study. Eur J Clin Microbiol Infect Dis 26(8):571–581CrossRefPubMed
44.
Zurück zum Zitat Berende A, ter Hofstede HJM, Vos FJ, van Middendorp H, Vogelaar ML, Tromp M et al (2016) Randomized Trial of Longer-Term Therapy for Symptoms Attributed to Lyme Disease. N Engl J Med 374(13):1209–20 Berende A, ter Hofstede HJM, Vos FJ, van Middendorp H, Vogelaar ML, Tromp M et al (2016) Randomized Trial of Longer-Term Therapy for Symptoms Attributed to Lyme Disease. N Engl J Med 374(13):1209–20
45.
Zurück zum Zitat Kalish RA, Kaplan RF, Taylor E, Jones-Woodward L, Workman K, Steere AC (2001) Evaluation of study patients with Lyme disease, 10–20-year follow-up. J Infect Dis 183(3):453–460CrossRefPubMed Kalish RA, Kaplan RF, Taylor E, Jones-Woodward L, Workman K, Steere AC (2001) Evaluation of study patients with Lyme disease, 10–20-year follow-up. J Infect Dis 183(3):453–460CrossRefPubMed
46.
Zurück zum Zitat Dersch R, Sarnes AA, Maul M, Hottenrott T, Baumgartner A, Rauer S et al (2015) Quality of life, fatigue, depression and cognitive impairment in Lyme neuroborreliosis. J Neurol 262(11):2572–2577CrossRefPubMed Dersch R, Sarnes AA, Maul M, Hottenrott T, Baumgartner A, Rauer S et al (2015) Quality of life, fatigue, depression and cognitive impairment in Lyme neuroborreliosis. J Neurol 262(11):2572–2577CrossRefPubMed
47.
48.
Zurück zum Zitat Matcham F, Ali S, Hotopf M, Chalder T (2015) Psychological correlates of fatigue in rheumatoid arthritis: a systematic review. Clin Psychol Rev 39:16–29CrossRefPubMed Matcham F, Ali S, Hotopf M, Chalder T (2015) Psychological correlates of fatigue in rheumatoid arthritis: a systematic review. Clin Psychol Rev 39:16–29CrossRefPubMed
49.
Zurück zum Zitat Lantos PM, Auwaerter PG, Wormser GP (2014) A systematic review of Borrelia burgdorferi morphologic variants does not support a role in chronic Lyme disease. Clin Infect Dis 58(5):663–671CrossRefPubMed Lantos PM, Auwaerter PG, Wormser GP (2014) A systematic review of Borrelia burgdorferi morphologic variants does not support a role in chronic Lyme disease. Clin Infect Dis 58(5):663–671CrossRefPubMed
Metadaten
Titel
Neuroborreliose – Diagnostik, Therapie und Verlauf
verfasst von
Dr. R. Dersch
S. Rauer
Publikationsdatum
07.02.2017
Verlag
Springer Medizin
Erschienen in
Der Nervenarzt / Ausgabe 4/2017
Print ISSN: 0028-2804
Elektronische ISSN: 1433-0407
DOI
https://doi.org/10.1007/s00115-016-0263-1

Weitere Artikel der Ausgabe 4/2017

Der Nervenarzt 4/2017 Zur Ausgabe

Mitteilungen der DGN

Mitteilungen der DGN

Mitteilungen der DSG

Mitteilungen der DSG

Mitteilungen der DGPPN

Mitteilungen der DGPPN